阿斯特捷利康股價重挫 7%，先前傳出與必治妥施貴寶進行價值 4000 億美元的合併談判
· cnbc.com
《金融時報》週日報導，兩家公司已就潛在的合併事宜進行了數月的討論。
AstraZeneca shares dropped as much as 7% after a report that the U.K.'s largest drugmaker was in talks with U.S. peer Bristol Myers Squibb over a megadeal that,...